Goserelin Cannot Improve the Weakness of a Patient with Kennedy Disease after 40-Week AdministrationSHI, Zhi-Guang; JIANG, De-Ke; MEI ZHAO et al.CNS neuroscience & therapeutics (Print). 2012, Vol 18, Num 12, pp 1021-1023, issn 1755-5930, 3 p.Article

Goserelin acetate as treatment for recurrent endometrial carcinoma: A Gynecologic Oncology Group studyASBURY, Robert F; BRUNETTO, Virginia L; LEE, Roger B et al.American journal of clinical oncology. 2002, Vol 25, Num 6, pp 557-560, issn 0277-3732, 4 p.Article

Anaphylactic Reaction to Different Gonadotropin-Releasing Hormone Agonists for the Treatment of EndometriosisLÜCHINGER, Annemarie B; MIJATOVIC, Velja; RUSTEMEYER, Thomas et al.The American journal of the medical sciences (Print). 2011, Vol 341, Num 3, pp 240-242, issn 0002-9629, 3 p.Article

Cutaneous endometriosis: a combination of medical and surgical treatmentKANG, S.-K; LEE, M.-W; CHOI, J.-H et al.Journal of dermatological treatment. 2002, Vol 13, Num 4, pp 189-192, issn 0954-6634, 4 p.Article

Orchidectomy versus Zoladex® plus Eulexin® in patients with metastatic prostate cancer (EORTC 30853)DENIS, L; ROBINSON, M; VERMEYLEN, K et al.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 6, pp 951-959, issn 0960-0760, 9 p.Conference Paper

Current pharmacotherapy of central precocious puberty by GnRH analogs: certainties and uncertaintiesBERTELLONI, Silvano; BARONCELLI, Giampiero I.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 12, pp 1627-1639, issn 1465-6566, 13 p.Article

Efficacy of a Second Line Luteinizing Hormone-Releasing Hormone Agonist After Advanced Prostate Cancer Biochemical RecurrenceLAWRENTSCHUK, Nathan; FERNANDES, Kimberly; BELL, David et al.The Journal of urology. 2011, Vol 185, Num 3, pp 848-854, issn 0022-5347, 7 p.Article

Parenteral medroxyprogesterone for the management of luteinizing hormone releasing hormone induced hot flashes in men with advanced prostate cancerLANGENSTROER, Peter; KRAMER, Brandon; CUTTING, Bradley et al.The Journal of urology. 2005, Vol 174, Num 2, pp 642-645, issn 0022-5347, 4 p.Article

Données actuelles de l'association radiothérapie-hormonothérapie dans les cancers de la prostate localisés et localement avancés = Association of hormonotherapy and radiotherapy in localized and locally advanced prostate cancerBOLLA, M.Médecine et hygiène. 1999, Vol 57, Num 2261, pp 1381-1384, issn 0025-6749, 3 p.Article

Efficacy of Zoladex LA (goserelin) in the treatment of girls with central precocious or early pubertyPATERSON, W. F; MCNEILL, E; REID, S et al.Archives of disease in childhood. 1998, Vol 79, Num 4, pp 323-327, issn 0003-9888Article

Multicenter randomized clinical trial of Goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer : An intergroup studyTAYLOR, C. W; GREEN, S; BEARDEN, J. D et al.Journal of clinical oncology. 1998, Vol 16, Num 3, pp 994-999, issn 0732-183XArticle

Goserelin versus leuprolide before hysterectomy for uterine fibroidsSOO SOO LIM; SOCKALINGAM, Jayanthi K; PENG CHIONG TAN et al.International journal of gynaecology and obstetrics. 2008, Vol 101, Num 2, pp 178-183, issn 0020-7292, 6 p.Article

Adjuvant goserelin in pre-menopausal patients with early breast cancer : Results from the ZIPP studyBAUM, M; HACKSHAW, A; HOUGHTON, J et al.European journal of cancer (1990). 2006, Vol 42, Num 7, pp 895-904, issn 0959-8049, 10 p.Article

Adjuvant goserelin improves clinical disease-free survival and reduces disease-related mortality in patients with locally advanced or localized prostate cancerAKAZA, H.BJU international (Papier). 2004, Vol 93, Num 1, pp 42-46, issn 1464-4096, 5 p.Article

3-Month formulation of goserelin acetate ('Zoladex' 10.8-mg depot) in advanced prostate cancer: Results from an italian, open, multicenter trialFONTANA, D; MARI, M; FRONGIA, M et al.Urologia Internationalis. 2003, Vol 70, Num 4, pp 316-320, issn 0042-1138, 5 p.Article

Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of goserelin in rabbit plasmaMIN KYUNG KIM; TAE HO LEE; YOUM, Jeong-Rok et al.Journal of chromatography. B. 2010, Vol 878, Num 24, pp 2235-2242, issn 1570-0232, 8 p.Article

The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trialSOYSAL, Seyide; SOYSAL, Mehmet Emin; OZER, Suzan et al.Human reproduction (Oxford. Print). 2004, Vol 19, Num 1, pp 160-167, issn 0268-1161, 8 p.Article

Survival analyses from the ZEBRA study: goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancerKAUFMANN, M; JONAT, W; BLAMEY, R et al.European journal of cancer (1990). 2003, Vol 39, Num 12, pp 1711-1717, issn 0959-8049, 7 p.Article

A new extra long acting depot preparation of the LHRH analogue Zoladex® : first endocrinological and pharmacokinetic data in patients with advanced prostate cancerDIJKMAN, G. A; FERNANDE DEL MORAL, P; PLASMAN, J. W. M. H et al.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 6, pp 933-936, issn 0960-0760, 4 p.Conference Paper

Goserelin with chemotherapy to preserve ovarian function in pre-menopausal women with early breast cancer: menstruation and pregnancy outcomesWONG, M; O'NEILL, S; WALSH, G et al.Annals of oncology. 2013, Vol 24, Num 1, pp 133-138, issn 0923-7534, 6 p.Article

Limits of Observational Data in Determining Outcomes From Cancer TherapyGIORDANO, Sharon H; KUO, Yong-Fang; ZHIGANG DUAN et al.Cancer. 2008, Vol 112, Num 11, pp 2456-2466, issn 0008-543X, 11 p.Article

Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancerFORWARD, D. P; CHEUNG, K. L; JACKSON, L et al.British journal of cancer. 2004, Vol 90, Num 3, pp 590-594, issn 0007-0920, 5 p.Article

Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole. DiscussionCARLSON, Robert W; HENDERSON, I. Craig; FORBES et al.Breast cancer research and treatment. 2003, Vol 80, pp S19-S28, issn 0167-6806, SUP1Conference Paper

Effective long-term suppression of pituitary-gonadal axis in prostatic cancer by Zoladex (ICI 118,630)MURPHY, G. P; GRECO, J; HUBEN, R et al.Urology (Ridgewood, NJ). 1987, Vol 30, Num 5, pp 482-483, issn 0090-4295Article

Endometriosis preoperative and postoperative medical treatmentVERCELLINI, Paolo; FRONTINO, Giada; DE GIORGI, Olga et al.Obstetrics and gynecology clinics of North America. 2003, Vol 30, Num 1, issn 0889-8545, x, 163-180 [19 p.]Article